Post-translational processing of pro-opiomelanocortin in the brattleboro (Di/di) rat pituitary

Research output: Contribution to journalArticleResearchpeer-review

Abstract

In homozygous (di/di) Brattleboro rats, pro-opiomelanocortin (POMC) synthesis and processing, and the release of its products, is by definition not under the control of hypothalamic arginine vasopressin (AVP) in contrast with normal rats or heterozygote (di/+) littermates. To explore the role of AVP on these parameters, we have compared homozygotes and heterozygotes in terms of POMC mRNA levels, pituitary content of iminunoreactive (ir)-ACTH, ir-)-endor-phin (f)-EP), a-melanocyte-stimulating hormone (a-MSH) and ir-N-acetvl-EP (NacEP), plasma levels of ir-ACTH and ir-p-EP, and RP-HPLC profiles of the various forms of ir-a-MSH and ir-NacEP. Homozygous rats had immeasurably low levels of hypothalamic ir-AVP, in contrast with their heterozygote littermates; hypothalamic ir-corticotropin releasing factor did not differ between strains. No difference between-strains was seen in levels of POMC mRNA; elevated levels of all pituitary peptides, except ir-ACTH, were found in di/di rats; plasma levels of both ir-ACTH and ir-P-EP were lower in di/di rats; pituitary ir-a-MSH RP-HPLC profiles were similar in both strains, but those for ir-NacEP showed a striking increase in Naca-EP in di/di rats. We interpret these data as evidence for decreased degradation/retarded release of POMC products from the di/di anterior pituitary, for increased processing of POMC products to shorter forms in both anterior pituitary and neuro-intermediate lobe, and thus for a role of AVP in the processing of POMC, as well as POMC synthesis and ACTH/p-EP release.

Original languageEnglish
Pages (from-to)603-610
Number of pages8
JournalNeuroendocrinology
Volume48
Issue number6
DOIs
Publication statusPublished - 1 Jan 1988
Externally publishedYes

Keywords

  • Adrenocorticotropin
  • Alpha-melanocyte-stimulating hormone
  • Arginine vasopressin
  • Beta-endorphin
  • N-acetylation
  • Stress

Cite this

@article{fbcd8c9e6057411292931a7c4b253276,
title = "Post-translational processing of pro-opiomelanocortin in the brattleboro (Di/di) rat pituitary",
abstract = "In homozygous (di/di) Brattleboro rats, pro-opiomelanocortin (POMC) synthesis and processing, and the release of its products, is by definition not under the control of hypothalamic arginine vasopressin (AVP) in contrast with normal rats or heterozygote (di/+) littermates. To explore the role of AVP on these parameters, we have compared homozygotes and heterozygotes in terms of POMC mRNA levels, pituitary content of iminunoreactive (ir)-ACTH, ir-)-endor-phin (f)-EP), a-melanocyte-stimulating hormone (a-MSH) and ir-N-acetvl-EP (NacEP), plasma levels of ir-ACTH and ir-p-EP, and RP-HPLC profiles of the various forms of ir-a-MSH and ir-NacEP. Homozygous rats had immeasurably low levels of hypothalamic ir-AVP, in contrast with their heterozygote littermates; hypothalamic ir-corticotropin releasing factor did not differ between strains. No difference between-strains was seen in levels of POMC mRNA; elevated levels of all pituitary peptides, except ir-ACTH, were found in di/di rats; plasma levels of both ir-ACTH and ir-P-EP were lower in di/di rats; pituitary ir-a-MSH RP-HPLC profiles were similar in both strains, but those for ir-NacEP showed a striking increase in Naca-EP in di/di rats. We interpret these data as evidence for decreased degradation/retarded release of POMC products from the di/di anterior pituitary, for increased processing of POMC products to shorter forms in both anterior pituitary and neuro-intermediate lobe, and thus for a role of AVP in the processing of POMC, as well as POMC synthesis and ACTH/p-EP release.",
keywords = "Adrenocorticotropin, Alpha-melanocyte-stimulating hormone, Arginine vasopressin, Beta-endorphin, N-acetylation, Stress",
author = "Canny, {Benedict J.} and {Ian Smith}, A. and Clements, {Judith A.} and Funder, {John W.}",
year = "1988",
month = "1",
day = "1",
doi = "10.1159/000125069",
language = "English",
volume = "48",
pages = "603--610",
journal = "Neuroendocrinology",
issn = "0028-3835",
publisher = "Karger",
number = "6",

}

Post-translational processing of pro-opiomelanocortin in the brattleboro (Di/di) rat pituitary. / Canny, Benedict J.; Ian Smith, A.; Clements, Judith A.; Funder, John W.

In: Neuroendocrinology, Vol. 48, No. 6, 01.01.1988, p. 603-610.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Post-translational processing of pro-opiomelanocortin in the brattleboro (Di/di) rat pituitary

AU - Canny, Benedict J.

AU - Ian Smith, A.

AU - Clements, Judith A.

AU - Funder, John W.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - In homozygous (di/di) Brattleboro rats, pro-opiomelanocortin (POMC) synthesis and processing, and the release of its products, is by definition not under the control of hypothalamic arginine vasopressin (AVP) in contrast with normal rats or heterozygote (di/+) littermates. To explore the role of AVP on these parameters, we have compared homozygotes and heterozygotes in terms of POMC mRNA levels, pituitary content of iminunoreactive (ir)-ACTH, ir-)-endor-phin (f)-EP), a-melanocyte-stimulating hormone (a-MSH) and ir-N-acetvl-EP (NacEP), plasma levels of ir-ACTH and ir-p-EP, and RP-HPLC profiles of the various forms of ir-a-MSH and ir-NacEP. Homozygous rats had immeasurably low levels of hypothalamic ir-AVP, in contrast with their heterozygote littermates; hypothalamic ir-corticotropin releasing factor did not differ between strains. No difference between-strains was seen in levels of POMC mRNA; elevated levels of all pituitary peptides, except ir-ACTH, were found in di/di rats; plasma levels of both ir-ACTH and ir-P-EP were lower in di/di rats; pituitary ir-a-MSH RP-HPLC profiles were similar in both strains, but those for ir-NacEP showed a striking increase in Naca-EP in di/di rats. We interpret these data as evidence for decreased degradation/retarded release of POMC products from the di/di anterior pituitary, for increased processing of POMC products to shorter forms in both anterior pituitary and neuro-intermediate lobe, and thus for a role of AVP in the processing of POMC, as well as POMC synthesis and ACTH/p-EP release.

AB - In homozygous (di/di) Brattleboro rats, pro-opiomelanocortin (POMC) synthesis and processing, and the release of its products, is by definition not under the control of hypothalamic arginine vasopressin (AVP) in contrast with normal rats or heterozygote (di/+) littermates. To explore the role of AVP on these parameters, we have compared homozygotes and heterozygotes in terms of POMC mRNA levels, pituitary content of iminunoreactive (ir)-ACTH, ir-)-endor-phin (f)-EP), a-melanocyte-stimulating hormone (a-MSH) and ir-N-acetvl-EP (NacEP), plasma levels of ir-ACTH and ir-p-EP, and RP-HPLC profiles of the various forms of ir-a-MSH and ir-NacEP. Homozygous rats had immeasurably low levels of hypothalamic ir-AVP, in contrast with their heterozygote littermates; hypothalamic ir-corticotropin releasing factor did not differ between strains. No difference between-strains was seen in levels of POMC mRNA; elevated levels of all pituitary peptides, except ir-ACTH, were found in di/di rats; plasma levels of both ir-ACTH and ir-P-EP were lower in di/di rats; pituitary ir-a-MSH RP-HPLC profiles were similar in both strains, but those for ir-NacEP showed a striking increase in Naca-EP in di/di rats. We interpret these data as evidence for decreased degradation/retarded release of POMC products from the di/di anterior pituitary, for increased processing of POMC products to shorter forms in both anterior pituitary and neuro-intermediate lobe, and thus for a role of AVP in the processing of POMC, as well as POMC synthesis and ACTH/p-EP release.

KW - Adrenocorticotropin

KW - Alpha-melanocyte-stimulating hormone

KW - Arginine vasopressin

KW - Beta-endorphin

KW - N-acetylation

KW - Stress

UR - http://www.scopus.com/inward/record.url?scp=0024204417&partnerID=8YFLogxK

U2 - 10.1159/000125069

DO - 10.1159/000125069

M3 - Article

VL - 48

SP - 603

EP - 610

JO - Neuroendocrinology

JF - Neuroendocrinology

SN - 0028-3835

IS - 6

ER -